This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shamanin, V. A.
Right arrow Articles by Androphy, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shamanin, V. A.
Right arrow Articles by Androphy, E. J.

 Previous Article  |  Next Article 

Journal of Virology, April 2008, p. 3912-3920, Vol. 82, No. 8
0022-538X/08/$08.00+0     doi:10.1128/JVI.02466-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

hAda3 Degradation by Papillomavirus Type 16 E6 Correlates with Abrogation of the p14ARF-p53 Pathway and Efficient Immortalization of Human Mammary Epithelial Cells{triangledown}

Vladimir A. Shamanin,{ddagger} Pedja Sekaric,{ddagger} and Elliot J. Androphy*

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605

Received 15 November 2007/ Accepted 29 January 2008

Two activities of human papillomavirus type 16 E6 (HPV16 E6) are proposed to contribute to the efficient immortalization of human epithelial cells: the degradation of p53 protein and the induction of telomerase. However, the requirement for p53 inactivation has been debated. Another E6 target is the hAda3 protein, a p53 coactivator and a component of histone acetyltransferase complexes. We have previously described the role of hAda3 and p53 acetylation in p14ARF-induced human mammary epithelial cell (MEC) senescence (P. Sekaric, V. A. Shamanin, J. Luo, and E. J. Androphy, Oncogene 26:6261-6268, 2007). In this study, we analyzed a set of HPV16 E6 mutants for the ability to induce hAda3 degradation. E6 mutants that degrade hAda3 but not p53 could abrogate p14ARF-induced growth arrest despite the presence of normal levels of p53 and efficiently immortalized MECs. However, two E6 mutants that previously were reported to immortalize MECs with low efficiency were found to be defective for both p53 and hAda3 degradation. We found that these immortal MECs select for reduced p53 protein levels through a proteasome-dependent mechanism. The findings strongly imply that the inactivation of the p14ARF-p53 pathway, either by the E6-mediated degradation of p53 or hAda3 or by cellular adaptation, is required for MEC immortalization.


* Corresponding author. Mailing address: University of Massachusetts Medical School, LRB328, 364 Plantation St., Worcester, MA 01605. Phone: (508) 856-6605. Fax: (508) 856-6797. E-mail: elliot.androphy{at}umassmed.edu

{triangledown} Published ahead of print on 6 February 2008.

{ddagger} These authors contributed equally to the work.


Journal of Virology, April 2008, p. 3912-3920, Vol. 82, No. 8
0022-538X/08/$08.00+0     doi:10.1128/JVI.02466-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.